Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evolus Inc.

9.16
-0.4600-4.78%
Volume:222.27K
Turnover:2.06M
Market Cap:590.60M
PE:-10.31
High:9.57
Open:9.57
Low:9.14
Close:9.62
Loading ...

Evolus Inc Shares up Close to 4% at $14.92 After the Bell Following Results, Outlook

THOMSON REUTERS
·
05 Mar

Evolus Q4 2024 GAAP EPS $(0.11) Misses $(0.06) Estimate, Sales $78.947M Beats $78.256M Estimate

Benzinga
·
05 Mar

BRIEF-Evolus Q4 Gross Margin 66.7%

Reuters
·
05 Mar

BRIEF-Evolus Posts Q4 Net Revenue Of $79 Mln

Reuters
·
05 Mar

Evolus Inc: Broader European Launch Remains on Track for H2 2025 for Estyme

THOMSON REUTERS
·
05 Mar

Evolus Inc: Projects Its Total Net Revenue Can Reach at Least $700 Mln by 2028

THOMSON REUTERS
·
05 Mar

Evolus Q4 Adjusted Gross Margin 67.5%

THOMSON REUTERS
·
05 Mar

Evolus Inc: Qtrly Total Net Revenues $79.0 Mln

THOMSON REUTERS
·
05 Mar

Evolus Q4 Net REV $79 Mln

THOMSON REUTERS
·
05 Mar

Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance

Business Wire
·
05 Mar

Evolus Reaffirms 2025 Guidance

THOMSON REUTERS
·
05 Mar

Evolus Q4 Adj Income From Operations $6.7 Mln

THOMSON REUTERS
·
05 Mar

Evolus posts quarterly profit on strong sales of cosmetic injection

Reuters
·
05 Mar

Is Evolus, Inc. (EOLS) the Best Small Cap Pharma Stock to Buy Now?

Insider Monkey
·
03 Mar

Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences

Business Wire
·
27 Feb

Evolus (EOLS) Moves 5.5% Higher: Will This Strength Last?

Zacks
·
14 Feb

Evolus Price Target Maintained With a $27.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Feb

BUZZ-Evolus rises on FDA nod for anti-wrinkle gels

Reuters
·
14 Feb

Evolus Gets FDA Approval for Two Injectable Hyaluronic Acid Gels

Dow Jones
·
14 Feb

Evolus trading resumes

TIPRANKS
·
14 Feb